NAMS CIK: 1936258

NewAmsterdam Pharma Co N.V.

  • Netherlands
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
478
FY23:
347
FY24:
863
FY25:
676
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.52
FY23:
0.31
FY24:
1.21
FY25:
93.6
Total assets
Change from FY22 to FY25
millions USD
FY22:
478
FY23:
347
FY24:
865
FY25:
769

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
36.1
FY23:
49.9
FY24:
107
FY25:
85.8
(negative)
Change from FY22 to FY25
millions USD
FY22:
12.4
FY23:
8.81
FY24:
0.20
FY25:
0.07
(positive)
Change from FY22 to FY25
millions USD
FY22:
430
FY23:
288
FY24:
758
FY25:
683
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
478
FY23:
347
FY24:
865
FY25:
769

All amounts in millions USD Data sources:SEC EDGARTwelve Data